Journal of Experimental & Clinical Cancer Research
Journal of Experimental and Clinical Cancer Research is ranked in the first quartile of oncology journals in Journal Citation Reports and is the official …
Journal of Experimental and Clinical Cancer Research is ranked in the first quartile of oncology journals in Journal Citation Reports and is the official …
The OncoAlert Newsletter is now out for June 23-29, 2023
The OncoAlert Newsletter is now out for June 23-29, 2023
PURPOSE Datopotamab deruxtecan (Dato-DXd) is an antibody-drug conjugate consisting of a humanized antitrophoblast cell-surface antigen 2 (TROP2) monoclonal antibody linked to a potent, exatecan-derived topoisomerase…
Objective To describe the clinicopathological characteristics and survival outcomes of ovarian neuroendocrine neoplasms from a curated registry. Methods This is a retrospective cross-sectional study of…
Registration for the OncoAlert ASCO 5k to be held on June 1st, 2024 at 7am local time and will start at the Hyatt Regency McCormick…
EGFR is often found to be constitutively activated in human cancer. Dobersberger etΒ al. develop an engineering strategy for the generation of binding domains specifically recognizing…
DAY 1 (GU Oncology)February 5, 2024 Start 6pm CET 12 noon EST6pm-6:20 (CET)12 noon-12:20 (EST)Gilberto Morgan (20 min) FDA Approvals in Oncology, OncoAlert …
The OncoAlert Newsletter is now out for June 23-29, 2023
Registration for the OncoAlert ASCO 5k to be held on June 1st, 2024 at 7am local time and will start at the Hyatt Regency McCormick…
Registration for the OncoAlert ASCO 5k to be held on June 1st, 2024 at 7am local time and will start at the Hyatt Regency McCormick…